Smaller meals, lean proteins, adequate hydration, and reduced fat intake make the starting dose period significantly more comfortable
The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - A longitudinal cohort study
In the early 1900s, with the advent of new medical therapies and disease perspectives, novel strategies were employed to promote weight loss including thyroid hormone supplementation, and later, amphetamines [1]
In 2008, Novo Nordisk began testing a newer formulation of the GLP-1 analog, semaglutide against liraglutide
Clinical trials demonstrate approximately 22% total body weight loss over 72 weeks
This is called diabetic ketoacidosis (DKA) and usually only affects those with type 1 diabetes and is rare in type 2